Department of Gynecology, Binzhou Medical University Hospital, Binzhou, China.
Eur Rev Med Pharmacol Sci. 2022 Jun;26(11):3798. doi: 10.26355/eurrev_202206_28945.
The article "Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9, by Z.-H. Liu, W.-J. Liu, X.-Y. Yu, X.-L. Qi, C.-C. Sunu, published in Eur Rev Med Pharmacol Sci 2020; 24 (20): 10375-10382-DOI: 10.26355/eurrev_202010_23387-PMID: 33155193" has been retracted by the authors due to inaccuracies related to the misuse of Table I. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/23387.
文章“Circ_0005276 通过靶向 ADAM9 加重上皮性卵巢癌的发展,作者:Z.-H. Liu、W.-J. Liu、X.-Y. Yu、X.-L. Qi、C.-C. Sunu,发表于 Eur Rev Med Pharmacol Sci 2020;24(20):10375-10382-DOI:10.26355/eurrev_202010_23387-PMID:33155193”已被作者撤回,原因是与表 I 不当使用相关的不准确性。出版商对由此造成的任何不便表示歉意。https://www.europeanreview.org/article/23387。